Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
6.994
-10.736 (-60.55%)
Streaming Delayed Price
Updated: 3:24 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,432,230
Open
6.960
Bid (Size)
6.990 (3)
Ask (Size)
7.000 (4)
Prev. Close
17.73
Today's Range
6.221 - 8.700
52wk Range
4.775 - 34.80
Shares Outstanding
348,875,959
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views
Today 14:31 EDT
Via
Benzinga
Topics
Earnings
Exposures
Financial
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Today 13:19 EDT
Via
Benzinga
Performance
YTD
-56.30%
-56.30%
1 Month
-51.09%
-51.09%
3 Month
+29.52%
+29.52%
6 Month
-41.22%
-41.22%
1 Year
-79.55%
-79.55%
More News
Read More
Dow Dips 250 Points; US Weekly Jobless Claims Surge
Today 12:06 EDT
Via
Benzinga
Topics
Stocks
Exposures
US Equities
WBD Stock Pops as Warner Bros. Considers Streaming Spinoff
Today 11:53 EDT
Via
InvestorPlace
Agenus Loses More Than 50% Value On Thursday - Here's Why
Today 11:47 EDT
Via
Benzinga
Exposures
Product Safety
Why Is NKGen Biotech (NKGN) Stock Up 18% Today?
Today 11:30 EDT
Via
InvestorPlace
Why Is Agenus (AGEN) Stock Down 55% Today?
Today 10:42 EDT
Via
InvestorPlace
US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
Today 10:04 EDT
Via
Benzinga
Agenus Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for BOT/BAL in MSS Colorectal Cancer
Today 7:00 EDT
From
Agenus Inc.
Via
Business Wire
Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference
June 28, 2024
From
Agenus Inc.
Via
Business Wire
Cancer Therapy Evaluation Program Announces Availability of Botensilimab for Clinical Studies
June 27, 2024
From
Agenus Inc.
Via
Business Wire
Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors
June 17, 2024
From
Agenus Inc.
Via
Business Wire
Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50
June 13, 2024
From
Agenus
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 04, 2024
Via
Benzinga
Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
June 04, 2024
Via
Benzinga
Agenus Announces Virtual Annual Shareholders Meeting
June 04, 2024
From
Agenus Inc.
Via
Business Wire
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
May 30, 2024
Via
InvestorPlace
7 Biotech Stocks to Put on Your Breakthrough Radar
May 27, 2024
Via
InvestorPlace
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 24, 2024
From
Agenus Inc.
Via
Business Wire
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
May 23, 2024
From
Agenus Inc.
Via
Business Wire
Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
May 23, 2024
From
Agenus Inc.
Via
Business Wire
3 Magnificent Growth Stocks to Buy Hand Over Fist
May 22, 2024
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
May 16, 2024
From
Agenus Inc.
Via
Business Wire
Agenus (AGEN) Q1 2024 Earnings Call Transcript
May 07, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.